The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $113.71

Today's change-0.39 -0.34%
Updated May 23 11:12 AM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $113.71

Today's change-0.39 -0.34%
Updated May 23 11:12 AM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp down (U.S.)$0.39

Edwards Lifesciences Corp is lower today, dropping (U.S.)$0.39 or 0.34% to (U.S.)$113.71. Over the last five days, shares are unchanged, but have gained 21.35% over the last year to date. This security has underperformed the S&P 500 by 3.37% during the last year.

Key company metrics

  • Open(U.S.) $114.00
  • Previous close(U.S.) $114.09
  • High(U.S.) $114.23
  • Low(U.S.) $113.41
  • Bid / Ask(U.S.) $113.67 / (U.S.) $113.76
  • YTD % change+21.35%
  • Volume360,496
  • Average volume (10-day)1,440,645
  • Average volume (1-month)1,743,306
  • Average volume (3-month)2,075,485
  • 52-week range(U.S.) $81.12 to (U.S.) $121.75
  • Beta0.75
  • Trailing P/E37.63×
  • P/E 1 year forward31.98×
  • Forward PEG2.05×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.02
Updated May 23 11:12 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.25%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue884768739759
Total other revenue--------
Total revenue884768739759
Gross profit668555538557
Total cost of revenue216213201203
Total operating expense590567554590
Selling / general / administrative230234230229
Research & development129115113113
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)105744
Other operating expenses, total-4139
Operating income294200185169
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax294200185169
Income after tax230159141127
Income tax, total63424442
Net income230159141127
Total adjustments to net income--------
Net income before extra. items230159141127
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items230159141127
Inc. avail. to common incl. extra. items230159141127
Diluted net income230159141127
Dilution adjustment----0--
Diluted weighted average shares216218218217
Diluted EPS excluding extraordinary itemsvalue per share1.060.730.650.58
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.100.740.670.73